Guggenheim Capital LLC Iovance Biotherapeutics, Inc. Transaction History

Guggenheim Capital LLC

$12 Billion
Q4 2024

A detailed history of Guggenheim Capital LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 98,940 shares of IOVA stock, worth $419,505. This represents 0.01% of its overall portfolio holdings.

Number of Shares

98,940

Previous 109,820 9.91%

Holding current value

$419,505

Previous $1.03 Million 29.0%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$7.17 - $12.28 $78,009 - $133,606	-10,880 Reduced 9.91%	98,940 $732,000
Q3 2024 Nov 13, 2024	SELL	$7.28 - $11.9 $19,299 - $31,546	-2,651 Reduced 2.36%	109,820 $1.03 Million
Q2 2024 Aug 14, 2024	BUY	$7.78 - $14.19 $272,362 - $496,763	35,008 Added 45.19%	112,471 $902,000
Q1 2024 May 14, 2024	SELL	$7.59 - $17.47 $240,132 - $552,715	-31,638 Reduced 29.0%	77,463 $1.15 Million
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $360,033 - $969,907	109,101 New	109,101 $886,000
Q4 2022 Feb 14, 2023	SELL	$5.62 - $10.0 $3,169 - $5,640	-564 Reduced 0.5%	111,286 $711,000
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $159,160 - $218,950	-16,701 Reduced 12.99%	111,850 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $98,494 - $282,978	15,438 Added 13.65%	128,551 $1.42 Million
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $105,440 - $162,674	8,517 Added 8.14%	113,113 $1.88 Million
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $153,865 - $256,876	9,297 Added 9.76%	104,596 $2 Million
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $56,186 - $73,525	-2,761 Reduced 2.82%	95,299 $2.35 Million
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $141,058 - $285,658	8,638 Added 9.66%	98,060 $2.55 Million
Q1 2021 May 13, 2021	BUY	$28.67 - $52.59 $574,088 - $1.05 Million	20,024 Added 28.85%	89,422 $2.83 Million
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $371,333 - $665,593	-13,243 Reduced 16.02%	69,398 $3.22 Million
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $831,417 - $1.09 Million	-29,961 Reduced 26.61%	82,641 $2.72 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $3.06 Million - $4.62 Million	112,602 New	112,602 $3.09 Million

Others Institutions Holding IOVA

# of Institutions

342

Shares Held

247M

Call Options Held

2.51M

Put Options Held

3.5M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $669M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Iovance Biotherapeutics, Inc. Transaction History